Gerard van Grinsven, president and CEO of Cancer Treatment Centers of America, has resigned.
Here are five things to know about Mr. van Grinsven and his resignation.
1. Mr. van Grinsven is resigning "to pursue other interests."
2. During Mr. van Grinsven's tenure, he spearheaded a re-imagine initiative throughout CTCA, encouraging all departments, executives and CTCA employees to rethink their management style in regard to their respective functions on behalf of the patients they serve, officials said. As a result, a five-year model for future growth was recently introduced.
3. CTCA also launched a new medicine and science division during Mr. van Grinsven's tenure. The division is led by internationally renowned medical oncologist, Maurie Markman, MD.
4. Overall, Richard Stephenson, chairman and founder of CTCA, said Mr. van Grinsven "brought to CTCA a leadership style and level of business acumen that accelerated our growth," and "helped clarify our vision for how we will extend the delivery of patient-empowered care when, where and how our patients need it most in both new and innovative ways."
5. CTCA COO Steve Mackin and CTCA at Lumberton, N.C.-based Southeastern Regional Medical Center CEO Anne Meisner will jointly serve in a new Office of the President until a successor is named.
More articles on healthcare executive moves:
Health Care Transformation Task Force taps Jeff Micklos as executive director: 4 things to know
15 latest hospital, health system executive moves
Kaiser Permanente executive named president of Saint Alphonsus Regional Medical Center: 6 things to know